Probiotics and immunity

Andrea T. Borchers, Carlo Selmi, Frederick J Meyers, Carl L Keen, M. Eric Gershwin

Research output: Contribution to journalArticle

282 Citations (Scopus)

Abstract

Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, including the gastrointestinal tract. While this beneficial effect was originally thought to stem from improvements in the intestinal microbial balance, there is now substantial evidence that probiotics can also provide benefits by modulating immune functions. In animal models, probiotic supplementation is able to provide protection from spontaneous and chemically induced colitis by downregulating inflammatory cytokines or inducing regulatory mechanisms in a strain-specific manner. In animal models of allergen sensitization and murine models of asthma and allergic rhinitis, orally administered probiotics can strain-dependently decrease allergen-specific IgE production, in part by modulating systemic cytokine production. Certain probiotics have been shown to decrease airway hyperresponsiveness and inflammation by inducing regulatory mechanisms. Promising results have been obtained with probiotics in the treatment of human inflammatory diseases of the intestine and in the prevention and treatment of atopic eczema in neonates and infants. However, the findings are too variable to allow firm conclusions as to the effectiveness of specific probiotics in these conditions.

Original languageEnglish (US)
Pages (from-to)26-46
Number of pages21
JournalJournal of Gastroenterology
Volume44
Issue number1
DOIs
StatePublished - 2009

Fingerprint

Probiotics
Immunity
Allergens
Animal Models
Cytokines
Insurance Benefits
Atopic Dermatitis
Colitis
Immunoglobulin E
Intestines
Gastrointestinal Tract
Down-Regulation
Asthma
Newborn Infant
Inflammation
Therapeutics

Keywords

  • Dietary supplement
  • Innate immunity
  • Microflora
  • Nutritional immunology
  • Vaccine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Probiotics and immunity. / Borchers, Andrea T.; Selmi, Carlo; Meyers, Frederick J; Keen, Carl L; Gershwin, M. Eric.

In: Journal of Gastroenterology, Vol. 44, No. 1, 2009, p. 26-46.

Research output: Contribution to journalArticle

Borchers, Andrea T. ; Selmi, Carlo ; Meyers, Frederick J ; Keen, Carl L ; Gershwin, M. Eric. / Probiotics and immunity. In: Journal of Gastroenterology. 2009 ; Vol. 44, No. 1. pp. 26-46.
@article{0e033735a9dc44619ad64f15e7c0f2a0,
title = "Probiotics and immunity",
abstract = "Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, including the gastrointestinal tract. While this beneficial effect was originally thought to stem from improvements in the intestinal microbial balance, there is now substantial evidence that probiotics can also provide benefits by modulating immune functions. In animal models, probiotic supplementation is able to provide protection from spontaneous and chemically induced colitis by downregulating inflammatory cytokines or inducing regulatory mechanisms in a strain-specific manner. In animal models of allergen sensitization and murine models of asthma and allergic rhinitis, orally administered probiotics can strain-dependently decrease allergen-specific IgE production, in part by modulating systemic cytokine production. Certain probiotics have been shown to decrease airway hyperresponsiveness and inflammation by inducing regulatory mechanisms. Promising results have been obtained with probiotics in the treatment of human inflammatory diseases of the intestine and in the prevention and treatment of atopic eczema in neonates and infants. However, the findings are too variable to allow firm conclusions as to the effectiveness of specific probiotics in these conditions.",
keywords = "Dietary supplement, Innate immunity, Microflora, Nutritional immunology, Vaccine",
author = "Borchers, {Andrea T.} and Carlo Selmi and Meyers, {Frederick J} and Keen, {Carl L} and Gershwin, {M. Eric}",
year = "2009",
doi = "10.1007/s00535-008-2296-0",
language = "English (US)",
volume = "44",
pages = "26--46",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Probiotics and immunity

AU - Borchers, Andrea T.

AU - Selmi, Carlo

AU - Meyers, Frederick J

AU - Keen, Carl L

AU - Gershwin, M. Eric

PY - 2009

Y1 - 2009

N2 - Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, including the gastrointestinal tract. While this beneficial effect was originally thought to stem from improvements in the intestinal microbial balance, there is now substantial evidence that probiotics can also provide benefits by modulating immune functions. In animal models, probiotic supplementation is able to provide protection from spontaneous and chemically induced colitis by downregulating inflammatory cytokines or inducing regulatory mechanisms in a strain-specific manner. In animal models of allergen sensitization and murine models of asthma and allergic rhinitis, orally administered probiotics can strain-dependently decrease allergen-specific IgE production, in part by modulating systemic cytokine production. Certain probiotics have been shown to decrease airway hyperresponsiveness and inflammation by inducing regulatory mechanisms. Promising results have been obtained with probiotics in the treatment of human inflammatory diseases of the intestine and in the prevention and treatment of atopic eczema in neonates and infants. However, the findings are too variable to allow firm conclusions as to the effectiveness of specific probiotics in these conditions.

AB - Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, including the gastrointestinal tract. While this beneficial effect was originally thought to stem from improvements in the intestinal microbial balance, there is now substantial evidence that probiotics can also provide benefits by modulating immune functions. In animal models, probiotic supplementation is able to provide protection from spontaneous and chemically induced colitis by downregulating inflammatory cytokines or inducing regulatory mechanisms in a strain-specific manner. In animal models of allergen sensitization and murine models of asthma and allergic rhinitis, orally administered probiotics can strain-dependently decrease allergen-specific IgE production, in part by modulating systemic cytokine production. Certain probiotics have been shown to decrease airway hyperresponsiveness and inflammation by inducing regulatory mechanisms. Promising results have been obtained with probiotics in the treatment of human inflammatory diseases of the intestine and in the prevention and treatment of atopic eczema in neonates and infants. However, the findings are too variable to allow firm conclusions as to the effectiveness of specific probiotics in these conditions.

KW - Dietary supplement

KW - Innate immunity

KW - Microflora

KW - Nutritional immunology

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=59049086992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59049086992&partnerID=8YFLogxK

U2 - 10.1007/s00535-008-2296-0

DO - 10.1007/s00535-008-2296-0

M3 - Article

C2 - 19159071

AN - SCOPUS:59049086992

VL - 44

SP - 26

EP - 46

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 1

ER -